Winnipeg conference. What do the numbers mean?
Mascolini
M
M
D015492:AIDS Serodiagnosis; D016915:AIDS Vaccines; D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000453:epidemiology; D000163:Acquired Immunodeficiency Syndrome / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D000956:Antigens, Viral / Q000097:blood; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D003587:Cytomegalovirus / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D006069:Gonorrhea / Q000453:epidemiology; D015658:HIV Infections / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D015497:HIV-1 / Q000235:genetics; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D008297:Male; D009161:Mycobacterium / Q000302:isolation & purification; D065006:Papanicolaou Test; D010348:Patient Care Team; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000401:mortality / Q000503:physiopathology; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000097:blood*; D012002:Rectal Diseases / Q000453:epidemiology; D013045:Species Specificity; D018119:Stavudine / Q000009:adverse effects / Q000627:therapeutic use; D014626:Vaginal Smears; D015431:Weight Loss
D016915:AIDS Vaccines; D000956:Antigens, Viral; D000998:Antiviral Agents; D007376:Interleukin-2; D012367:RNA, Viral; D018119:Stavudine